Inhalation studies were conducted to determine the potential toxicity of HCFC-124. Groups of rats and mice were exposed to HCFC-124 6 hr/day, 5 days/week for 13 weeks at 0, 5000, 15,000, and 50,000 ppm. Subgroups of rats and mice were held for a 1 -month recovery period. A functional observational battery (FOB) was conducted on rats at 0,4, 8,13, and 16 weeks. Clinical pathology evaluations were conducted at 7, 13, and 17 weeks. Thirteen or 17 weeks after study initiation, rats and mice underwent gross and microscopic evaluation, and livers were evaluated for hepatic beta-oxidation activity. In addition, groups of female rats and rabbits were exposed to HCFC-124 by inhalation during gestation to 0, 5000, 15,000, or 50,000 ppm. Exposure of rats and mice to HCFC-124 caused minimal compound-related effects. Compoundrelated changes occured in several clinical pathology parameters in rats and mice. Hepatic beta-oxidation activity was significantly higher in 5000,15,000, and 50,000 ppm male mice; however, there were no compound-related effects on beta-oxidation activity in rats. During the daily exposures, rats, mice, and rabbits exposed to 50,000 ppm were less responsive to auditory stimuli or less active compared to controls. At the 13-week FOB, male rats exposed to 15,000 or 50,000 ppm had decreased arousal. There were no compound-related effects on mortality, clinical signs, ocular tissues, hematology parameters, organ weights, and tissue morphology at any concentration in rats or mice. Maternal toxicity in rats was evident by a significant decrease in weight gain and food consumption at 50,000 ppm. Similarly, 50,000 ppm pregnant rabbits had lower food consumption. However, for both rats and rabbits, there was no evidence of fetal toxicity at any concentration.
© 1996 Society of Toxicology Chlorotetrafluoroethane (HCFC-124) has been developed as a substitute for fully halogenated chlorofluorocarbons. It is intended for use as a component in refrigerant blends, and as a blowing agent for polystyrene and polyolefin foams.
HCFC-124 is a gas at room temperature with an ozone depleting potential of 0.022 (WMO, 1991) and a global warming potential of 0.10 (AER, 1992), relative to a reference value for both indices of 1.0 for chlorofiuorocarbon 11 (CFC-11).
HCFC-124 has a low acute toxicity with the 4-hr LC50 in rats estimated to be between 230,000 and 300,000 ppm (ECETOC, 1994) . Rats exposed to concentrations of 162,000-230,000 ppm had a temporary weight loss, decreased acoustic-startle response, postration, lethargy, and incoordination; however, the anesthetic changes resolved after the exposure period ended. Similar clinical signs were observed at concentrations of 300,000 ppm; however, six of six rats died during the exposure at this concentration.
Dogs exposed to HCFC-124 for 10 min at concentrations of 400,000 to 700,000 ppm exhibited light surgical anesthesia; however, complete recovery occurred within 7-10 min after cessation of exposure (Van Posnak and Artusio, 1960) .
In a 2-week study, rats were exposed to 0 or 100,000 ppm HCFC-124 6 hr per day, 5 days per week, for a total of 10 exposures (Trochimowicz et al., 1977) . A group of rats was necropsied immediately following the last exposure and the remaining rats were necropsied 14 days after the last exposure. During the exposure periods, rats exposed to 100,000 ppm exhibited poor coordination, lethargy, anesthesia, irregular respiration, and sporadic tremors. However, approximately 15 min after exposure, rats appeared to be normal. Body weight gain was slightly lower compared to that seen in control rats. At the end of the 2-week exposure period, rats exposed to HCFC-124 had lower thymus weight and depletion of the normal foamy appearance of liver hepatocytes. Rats necropsied 14 days postexposure had lower body weight, lower kidney weight, and lower thymus weight compared to control rats; however, no compound-related morphological changes were noted.
Similar to other halocarbon compounds (for example fluorocarbons 11, 12, and 114) (Mullin et al., 1972) , inhalation of 25,000 ppm HCFC-124 followed by an intravenous epinephrine challenge to simulate stress induced a cardiac sensitization response in dogs (Trochimowicz, 1993) .
The objectives of the studies reported here were: (1) to evaluate the subchronic toxicity of HCFC-124 when administered by inhalation to male and female rats and mice for approximately 90 days and (2) to determine the potential developmental toxicity of HCFC-124 in rats and rabbits when administered by inhalation.
Although there were only minimal compound-related effects in the 2-week study, 50,000 ppm was selected as the highest concentration since higher concentrations would have required the addition of supplemental oxygen to the chambers. The lower concentrations were selected as fractions of the 50,000 ppm concentration.
MATERIALS AND METHODS

Test Material
The test substance, HCFC-124 (2-chloro-l,l,l,2-tetrafluoroethane), is a vapor at room temperature (boiling point, -I 1°C; vapor pressure, 61 hPa) and is a clear, colorless liquid under pressure. The material was supplied by DuPont Fluoroproducts (Deepwater, NJ). Analytical purity of each cylinder of test material was determined by gas chromatography by DuPont Fluoroproducts. Minimum purity of the test material was 99%.
Test Species
Subchronic rat study. Ninety-five male and 95 female Crl:CD BR rats, approximately 21 days of age, were acquired from the viral antibody-free colony at Charles River Laboratories, Inc. (Raleigh, NC) Prior to being used in the study, each animal was evaluated for suitability during a 1-week quarantine period.
Subchronic mouse study. Ninety-one male and 95 female Crl:CD-I(ICR)BR mice, approximately 28 days of age, were acquired from the viral antibody-free colony at Charles River Laboratories, Inc. (St. Constant, Quebec, Canada) Prior to being used in the study, each animal was evaluated for suitability during a I-week quarantine period.
Rat developmental study. One hundred sixty-eight nulliparous female and 105 male Crl:CD BR rats, approximately 64 days old. were acquired from the viral antibody-free colony at Charles River Laboratories.
Rabbit developmental study. Ninety-five nulliparous female New Zealand White rabbits approximately 3.5-4.0 months old were acquired from Hazleton Research Products, Inc. (Denver, PA). An in-house colony of proven fertile breeder males from Hazleton Research Products was used for mating
Animal Husbandry
Rats and mice. Rats and mice were housed individually in suspended stainless steel, wire-mesh cages, males and females on separate cage racks. Rats and mice were housed separately. Cage racks were relocated within the animal room each week and cages were repositioned on the racks every 2 weeks. The animal rooms were maintained on a 12-hr light/dark cycle (fluorescent light) and targeted at a temperature of 23±2°C and a relative humidity of 55±15%.
Throughout the test period, except during exposure, Purina Certified Rodent Chow (chunk for the rats and mice designated for the subchronic studies and powdered for the rats designated for the developmental study) and tap water were available ad libitum.
Rabbits. Rabbits were housed individually except during mating in stainless steel suspended cages with wire mesh floors, tops, and fronts, and with subcage floor pans. The animal rooms were maintained on a 12-hr light/dark cycle and targeted at a temperature range of 16-2TC and a relative humidity of 40-60%.
During the acclimation period, rabbits received approximately 150 g of Purina Certified Rabbit Chow (high fiber). During the nonexposure periods of the gestation phase, food and tap water were available ad libitum. During exposure, food, and water were not available.
Test Design
Subchronic rat and mouse studies. Animals were divided by computerized, stratified randomization into four groups of 20 males and four groups of 20 females, so that there were no statistically significant differences among group body weight means within a sex. The order of animals within each group was randomized. Each group within a sex was designated as either a control (0 ppm), 5000, 15,000, or 50,000 ppm HCFC-124 exposure level. Ten rats and mice were randomly selected from each group and designated to be sacrificed at the end of the 90-day study. The remaining 10 animals per group were designated to recover for approximately 1 month after the 90-day period.
Rat and rabbit developmental studies. Mated rats were ranked by their body weights on gestation Day (GD) I and assigned to control or three experimental groups by random sampling from strata established within the ranked list such that each of the four groups contained 24 females. Mated rabbits were assigned to test groups daily in order to provide an equal distribution of mated females among groups and to equalize the GD 0 mean group body weights. Each group consisted of 20 females. Groups of rats or rabbits were designated as either a control (0 ppm), 5000, 15,000, or 50,000 ppm HCFC-124.
Test Chambers and Operation
Subchronic rat study and rat developmental study. The rats designated for the developmental study were exposed together with the rats assigned to the subchronic study. Four 1.4 m 3 stainless steel and glass exposure chambers were used for the exposures. The chambers were operated in a one-pass, flow-through mode with the air flow rates targeted at 300 liters/ min. During exposure, the airflow rates, temperature, and relative humidity of the chamber air were recorded at approximately 5-min intervals. Chamber oxygen content was determined at least twice daily. During exposure, rats were housed two per cage.
Rats designated for subchronic toxicity were exposed for 6 hr per day, 5 days per week, over a 90-day period (weekends and holidays excluded). Male rats received a total of 65 exposures and female rats received a total of 66 exposures. Exposures for rats dedicated to the developmental study were conducted 6 hr per day during GD 7-16.
Mouse subchronic study. Four 150-liter stainless steel and glass exposure chambers were used for the exposures. The chambers were operated in a one-pass, flow-through mode with the air flow rates maintained at 30 liters/min. During exposure, the temperature of the chamber air was recorded at approximately 60-min intervals. Chamber oxygen content and relative humidity were determined at least twice daily.
Exposures were conducted for 6 hr per day. 5 days per week, over a 90-day period (weekends and two holidays excluded). During exposure, mice were housed individually. Male mice received a total of 65 exposures and female mice received a total of 66 exposures.
Developmental rabbit study. Four 6000-liter stainless steel and glass exposure chambers were used for the exposures The chambers were operated in a one-pass, flow-through mode with the air flow rates of approximately 1200 liters/min. During exposure, the airflow rates, temperature, and relative humidity of the chamber air were recorded at approximately 30-min intervals. Exposures were conducted for 6 hr per day, during GD 6-18.
For all three species, the exposures were conducted during the same 8-hr period of the day to minimize diurnal physiological variations. Before Downloaded from https://academic.oup.com/toxsci/article-abstract/32/1/11/1644792 by guest on 27 February 2019 transfer to housing facilities at the end of each exposure, test groups were left in their respective exposure chambers for a period sufficient to allow clearance of test material from the chamber atmosphere as determined by atmospheric analysis.
Atmosphere Generation and Analyses
The test material was introduced into the chamber air supply as a vapor. It was mixed with incoming conditioned air by turbulence. Chamber concentrations of HCFC-124 were controlled by varying the vapor flow rates into the exposure chamber. Conditioned air alone was metered in an identical manner into the respective control chambers. To maintain the cylinders containing the test material at a constant temperature, they were warmed to offset the temperature decrease due to volatilization of the liquid material.
Chamber atmospheres were analyzed by gas chromatography at approximately 30-min intervals during each 6-hr exposure period. Samples were drawn by vacuum pump from representative areas of the chambers where the animals were exposed. Although different model gas chromatographs and columns were used in these four studies, the analytical procedures were similar and have been summarized as follows: Gas samples were analyzed with a gas chromatograph equipped with a flame ionization detector. Nitrogen was utilized as the carrier gas. Samples were chromatographed isothermally on stainless steel columns packed with either 2% OV-101 on 100/ 120 mesh Chromosorb WHP or Porapak Q 100/120 mesh. The atmospheric concentration of HCFC-124 was determined by comparing the detector response of chamber samples to that of gas standards through the use of standard curves. The gas standards were prepared by injecting known volumes of HCFC-124 vapor into gas bags which contained known volumes of air.
In Vivo Parameters for Subchronic Rat and Mouse Studies
All rats and mice were weighed once per week throughout the study. The amount of food consumed by each sex per group was determined once per week throughout the study. From these determinations and body weight data, mean individual daily food consumption, and food efficiency were calculated.
Cage-site examinations to detect moribund or dead animals and abnormal behavior and appearance were conducted twice daily throughout the study. At every weighing, each animal was individually handled and examined for abnormal behavior and appearance, and palpable masses.
Ophthalmological examinations were conducted by a veterinary ophthalmologist prior to the first exposure, and prior to the 90-day sacrifice. At least 1 hr before each examination, one or two drops of 1 % atropine sulfate solution were placed in each eye of every animal. Both eyes were examined by focal illumination and indirect ophthalmoscopy. The examinations were conducted under subdued lighting.
A functional observational battery (FOB) (Irwin, 1968 ) was conducted at 0, 4, 8, 13, and 16 weeks on 10 rats per group designated for recovery (see below). The FOB conducted on weeks 4, 8, and 13 occurred on nonexposure days (such as weekends), beginning approximately 18 hr after the preceding exposure period. Rats were counterbalanced by sex and by dose group over time to minimize the influence of uncontrolled factors. The experimenter conducting the FOB was blind with respect to treatment group of each rat. While in the home cage, each rat was observed and scored for posture, palpebral closure, writhing, circling, biting, and vocalization. Upon removal from the cage, the following were recorded: ease of removal, ease of handling, piloerection, bite marks on tail and/or paws, palpebral closure, fur appearance, lacrimation, and salivation. In a free roaming space, presence or absence of the following were recorded: convulsions, grooming, gait abnormalities, degree of locomotion, arousal, and responses to approach, touch, finger snap, and tail pinch. In addition, pupillary response, grip strength, hind limb foot splay, and presence or absence of diarrhea and urination were assessed.
Clinical laboratory evaluations were conducted on 10 rats and mice per sex per concentration at approximately 45 and 90 days after initiation of the study, and on surviving animals at the conclusion of the recovery period. A complete blood cell count (CBC), serum biochemical panel (20 analytes), uinalysis, and plasma and urine fluoride were evaluated for each rat. In addition, for each mouse, a CBC and partial biochemical panel were conducted.
At the conclusion of the 90-day period, 10 rats per sex per concentration and 10 mice per sex per concentration were allowed to recover for approximately 1 month. During the recovery period, exposures were not conducted, but in-life observations and measurements (clinical observations, body weight, and food consumption) were continued.
Pathological Evaluation for Subchronic Rat and Mouse Studies
After approximately 90 days on test, the 10 rats per sex per concentration and 10 mice per sex per concentration designated for the 90-day portion of the study were sacrificed and necropsied. Approximately 1 month later, all surviving rats and mice which were designated for recovery were sacrificed and necropsied.
The lungs, brain, heart, liver, spleen, kidneys, ovaries, adrenals, and testes were weighed, and organ weight/final body weight ratios were calculated.
The following tissues were collected from all rats: skin, bone marrow, lymph nodes, spleen, thymus, aorta, heart, nose, trachea, lungs, larynx, pharynx, salivary glands, esophagus, stomach, liver, pancreas, small intestine, large intestine, tongue, kidneys, bladder, pituitary, thyroid-parathyroid, adrenals, prostate, mammary gland, testes, ovaries, epididymides, uterus, seminal vesicles, vagina, brain, spinal cord, peripheral nerve, bone, muscle, eyes, exorbital lacrimal glands, harderian glands, and all gross lesions. Collected tissues were preserved in an appropriate fixative until processed. All tissues collected from rats and mice in the 50,000 ppm group and control group were further processed to slides, stained with hematoxylin and eosin, and examined microscopically. Nose, lungs, liver, kidneys, and all gross lesions from animals in the intermediate groups were processed to slides and examined microscopically.
Determination of Hepatic Peroxisome Proliferation in the Subchronic Rat and Mouse Studies
A representative sample of liver was collected and frozen (-85°C) from five rats per sex per concentration and five mice per sex per concentration sacrificed at the 90-day and recovery sacrifices (recovery samples for rats were not analyzed). Each sample was analyzed for peroxisomal beta-oxidation activity of fatty acids by the method of Lazarow (1981) . The peroxisomal fraction was incubated with a reaction mixture containing [
I4 C]-palmitoyl-CoA. Following centrifugation, the radioactivity from the formation of acid soluble [14C]acetyl-CoA was measured by liquid scintillation spectrometry.
In Vivo and Postmortem Procedures for the Rat Developmental Study
Females were mated with males (1:1) over a 2-week period, and females with confirmed copulation were assigned to six breeding lots (A-F). Females were weighed on GD I, 7-17, and 22. Food consumption was determined on GD I, 3, 5, 7, 9, 11, 13, 15, 17, 19, and 22 , and individual clinical signs were recorded each morning on GD 1 -22 and in the afternoon on GD7-16.
Females were sacrificed with CO 2 on GD 22 and were examined for gross pathologic changes. The gravid uterus was removed, weighed, opened, and the types of nidations (live or dead fetuses, early or late resorptions) and their relative positions were recorded. The empty uterine weight and number of corpora lutea for each ovary also were recorded. The uterus of each apparently "nonpregnant" rat was opened and stained with ammonium sulfide according to the method of Salewski (1964) to detect very early resorptions.
The corpora lutea (CL) counts and nidation data were used to calculate Downloaded from https://academic.oup.com/toxsci/article-abstract/32/1/11/1644792 by guest on 27 February 2019 the percentage preimplantation and postimplantation loss. These were calculated, on a litter basis, by dividing the differences between CL and nidations by the CL count (preimplantation loss) or the difference between nidations and live fetuses by the nidation count (postimplantation loss); both results were then multiplied by 100. Live fetuses were weighed, sexed, and examined for external alterations. For each litter, the maximum stunted weight (MSW) was calculated by subtracting the lightest weight from the total weight, dividing by the remaining number of fetuses, and multiplying by 0.666. A fetus weighing the same or less than the MSW was considered stunted; its weight was omitted when the mean litter weight was calculated.
The first live fetus in the litter, and every other fetus thereafter, was decapitated and examined for visceral alterations according to the method of Staples (1974) . The heads were fixed in Bouin's solution and examined according the the methods of Barrow and Taylor (1969) . All stunted and externally malformed fetuses also were examined for visceral alterations; a decision to do a head examination was made on an individual basis.
The remaining fetuses were sacrificed by an ip injection of sodium pentobarbital. All fetuses were fixed in 70% ethanol, eviscerated, macerated in 1% aqueous potassium hydroxide solution, stained with alizarin red S, and examined for skeletal alterations.
In Vivo and Postmortem Procedures for the Rabbit Developmental Study
Females were mated with two males, and when coitus was observed with the second male, the female was considered mated and returned to her cage. Females were weighed on GD 1, 6-19, and 30. Food consumption was determined over the following intervals: GD 0-1, 3-4, 5-6, 6-7, 7-8, 8-9, 9-10, 10-11, 11-12, 12-13, 13-14, 14-15, 15-16, 16-17, 17-18, 18-19, 19-20, 24-25, and 29-30 . Animals were observed twice daily for pharmacologic or toxicologic effects and mortality. In addition, a detailed physical examination of each animal occurred on GD 0, 6-18, 24, and 30.
Females were sacrificed by an IV overdose of sodium pentobarbital on GD 30 and were examined for gross pathologic changes. The liver from females sacrificed on GD 30 was weighed. The gravid uterus (with ovaries attached) was removed, weighed, opened, and the types of nidations (live or dead fetuses, early or late resorptions, and implantation sites) and their relative positions were recorded. The empty uterine weight and number of corpora lutea for each ovary also were recorded. The uterus of each apparently "nonpregnant" rabbit was opened and stained with ammonium sulfide according to the method of Salewski (1964) to detect very early resorptions Fetuses were weighed, sexed, and examined for external alterations Live fetuses were killed by ip injection of sodium pentobarbital euthanasia solution and examined for visceral alterations according to the method of Staples (1974) . Following the microdisection procedure, the viscera were removed from the thoracic and abdominal cavities and discarded. The eviscerated fetuses were then skinned and the eyes were evaluated grossly for obvious malformations. The ventricles of the brain were also evaluated grossly. The eviscerated, skinned fetal specimens were then processed for staining of the ossified skeletal structures with alizarin red S and examined for skeletal alterations. Fetuses/pups which were delivered prematurely during GD 26-30 were evaluated for external malformation, eviscerated, and processed for staining of the skeletal structures.
Statistical Analyses
Body weight, body weight gain, food consumption, organ weights, hepatic peroxisomal beta-oxidation activity data, and clinical chemistry parameters were analyzed by a one-way analysis of variance. When the corresponding F test for differences among test group means was significant, pairwise comparisons between test and control groups were made with the Dunnett's test. Bartlett's test for homogeneity of variances was performed on the organ weight and clinical laboratory data from the subchronic studies and on body weight and food consumption data from the rabbit teratology study. When the results of the Bartlett's test were significant at alpha <0.005, the Kruskal-Wallis test was employed and the Mann-Whitney U test or Dunn"s test was used to compare means from the control groups and each of the groups exposed to HCFC-124.
The incidence of pregnancy, clinical observations, maternal mortality, and females with total resorptions was evaluated by the Cochran-Armitage test for trend and Fisher's exact test (with a Bonferroni correction for clinical signs data).
The number of live fetuses, dead fetuses, resorptions, nidations, corpora lutea, preimplantation loss, postimplantation loss, fetal weight, and incidence of fetal alterations were evaluated by Jonckheere's test and the MannWhitney U test.
RESULTS
Chamber Concentration and Environmental Conditions
The overall mean concentrations of HCFC-124 in the exposure chambers for the 90-day rat, 90-day mouse, rat developmental, and rabbit developmental studies during their respective exposure periods were within 98-101% of the target concentrations of 0, 5000, 15,000, and 50,000 ppm (Table 1 ). In addition, the standard deviations for the overall mean daily chamber concentrations ranged between 2 and 6% of the target concentrations. Mean daily chamber temperatures across all four studies ranged between 20 and 27°C, and mean daily chamber humidity ranged between 35 and 78%. The chamber environmental conditions were judged to be satisfactory to maintain the health status of the animals.
90-Day Rat Study
Body weight and body weight gain were similar among all concentrations for both males and females. There were no compound-related effects on food consumption or food efficiency at any concentrations in either males or females. The incidence of clinical signs was similar among all exposure concentrations and no unscheduled deaths occurred during the course of the study.
Responsiveness of animals visible through the chamber window was assessed by rapping on the chamber window near the beginning of the daily exposure period, approximately 3 hr after study start, and near the end or after the exposure period. During exposure, rats exposed to 50,000 ppm were generally less responsive to auditory stimuli than rats exposed to 0, 5000, or 15,000. However, at approximately test Day 19 (exposure Day 13), rats exposed to 50,000 ppm demonstrated a more variable response to the auditory stimuli presented during the exposure period, with responsiveness similar to control rats on some occasions. The responsiveness of all animals to auditory stimuli at the beginning of the daily exposure periods and after the exposure periods was similar to control.
Compound-related changes were observed in 1 of 36 neurobehavioral parameters. Four of 10 males exposed to 15,000 ppm and 6 of 10 males exposed to 50,000 ppm had significantly decreased arousal in a free roaming space during the Week 13 FOB (Table 2 ). This effect was not observed in female rats. However, during the recovery period, there were no differences in any of the behavioral parameters between control and exposure groups.
Compound-related differences in hematology parameters were not evident at any concentration in either males or females.
Serum triglyceride concentrations were significantly lower in 15,000 and 50,000 ppm males at the 45-day sampling period (Table 3) . At the 90-day sampling period, triglycerides values in the 15,000 and 50,000 ppm males were minimally lower; however, they were not statistically significant. During the recovery period, 4 of 10 male rats in the 15,000 and 50,000 ppm groups still had low triglyceride values compared to the control mean; however, due to the variability of the control data, these differences were considered to be equivocal. Although the difference was minimal at the 45-day evaluation and was equivocal at 90 days, the lower triglyceride concentration in 15,000 and 50,000 ppm males was considered to be compound related.
Alkaline phosphatase activity was elevated in females exposed to 50,000 ppm at the 90-day evaluation and was considered to be compound related (Table 3) . However, during the recovery period, alkaline phosphatase values were similar to control for all exposure concentrations.
Plasma fluoride concentration was increased at the 90-day sacrifice in 5000, 15,000, and 50,000 ppm males and females (Table 3 ). In addition, by the end of the 1-month recovery period, plasma fluoride concentration remained elevated in 15,000 and 50,000 ppm males. Urinary fluoride concentration was elevated (2-to 5-fold above controls for males and 4-to 10-fold for females) at all exposure concentrations for the 45-and 90-day sampling periods. Urinary fluoride concentration continued to be elevated by the end of the recovery period; however, the concentration was less than 2-fold higher than control values in both males and females. The fractional clearance rate of fluoride was similarly elevated in males and females at the 90-day sampling period at all exposure concentrations and in males after 1 month of recovery. These results suggest that elimination of fluoride ion may be different in male and female rats. Based on the fractional clearance rate of fluoride at the 90-day sampling period, the fraction of filtered fluoride ion eliminated in the urine is higher in females than in males. The higher concentrations of plasma fluoride and urinary fluoride and the higher fractional clearance rate of fluoride were expected physiological consequences of exposure to the test material and were not considered to be adverse. At the 90-day sampling period, males exposed to 15,000 or 50,000 ppm HCFC-124 exhibited a mild diuresis characterized by increased urine volume and decreased osmolality. The diuresis appears to be the result of increased osmotic activity from the excreted fluoride ions, and therefore is not considered to be a direct effect of the compound.
There were no compound-related effects on ophthalmoscopically visible structures of the eye in either males or females at any exposure concentration. All abnormalities were considered to be spontaneous in this strain or the result of trauma from orbital sinus bleeding. There were no compound-related effects on organ weight parameters at any exposure concentration at either the 90-day or recovery sacrifice. Males exposed to 10,000 ppm had decreased absolute spleen weights; however, since a doseresponse relationship was not evident, it was not considered to be compound related. There were no compoundrelated gross or microscopic morphological changes detected at any exposure concentration at either the 90-day sacrifice or after 1 month of recovery.
Hepatic beta-oxidation activity in liver samples collected at the 90-day sacrifice was similar to control at all exposure concentrations in both male and female rats (Table 4) .
90-Day Mouse Study
Males exposed to 5000 or 15,000 ppm had lower body weight compared to control values during test Days 85-106 (not statistically significant for test Day 99 which was the beginning of the recovery period) (Fig. 1) . In addition, although not statistically significant, the body weights of 50,000 ppm males were slightly lower than control values for weeks 12-15. Cumulative body weight gain over the 90-day interval was significantly lower than control values for male mice exposed to 5000, 15,000, or 50,000 ppm, although a dose-related trend was not evident. These slight differences in body weight and body weight gain may be secondary to the lower serum triglycerides (Table 3) . This hypothesis is supported by the slightly greater body weight gain observed during the recovery period (test Days 92-120 in 5000, 15,000, and 50,000 ppm males) than that seen in controls. Body weights of female mice were similar to control values at all exposure concentrations. Body weight gain was lower for 5000 and 50,000 ppm females on test Days 29-36 and was significantly higher for 5000 ppm females on test Days 64-71 (Fig. 1) . These transient differences in the female mice were not considered biologically significant.
There were no compound-related effects on food consumption at any concentration in either males or females.
Responsiveness of mice visible through the chamber window was assessed by rapping on the chamber window several times throughout the daily exposure period. There were no apparent differences in responsiveness to auditory stimuli in mice exposed to 5000 or 15,000 ppm compared to that seen in controls. However, mice exposed to 50,000 ppm were generally less responsive to auditory stimuli during exposure. When the mice were returned to their home cages after the daily exposure periods, there were no differences in responsiveness at any exposure concentration compared to that seen in controls. There were no compound-related effects on the incidence of clinical signs of toxicity in either male or female mice at any exposure concentration. Several unscheduled deaths occurred during the course of the study; however, the causes of death (which included accidental injuries, pneumonia, skin abscess, and undetermined causes) were not compound related. The incidences of mortality among male mice were 5% (1/20), 0% (0/20), 10% (2/20), and 15% (3/20) for the 0, 5000, 15,000, and 50,000 ppm groups, respectively. For female mice, the incidences of mortality were 5% (1/20), 15% (3/20), 30% (6/20), and 5% (1/20).
Compound-related differences in hematology parameters were not evident for any exposure concentration in either males or females at either the 45-day, the 90-day, or the recovery clinical evaluations.
Minimal compound-related changes in clinical chemistry parameters were noted. At the 45-day clinical evaluation, there were no compound-related effects on triglycerides, glucose, or cholesterol in either males or females at any exposure concentration. At the 90-day clinical evaluation, male mice exposed to 15,000 ppm and 50,000 ppm had significantly lower serum triglycende concentrations compared to control values (Table 3 ). Males exposed to 5000 ppm also had slightly lower triglycerides (but not statistically significant) than seen in control values. At the end of the 1-month recovery period, there were no compound-related differences in any of the clinical chemistry parameters evaluated.
There were no compound-related effects on ophthalmoscopically visible structures of the eye in either males or females at any exposure concentration. All abnormalities were considered to be spontaneous in this strain or as a result of trauma from orbital sinus bleeding. Absolute kidney weights and absolute heart weights were lower for 5000, 15,000, and 50,000 ppm males. In addition, mean relative heart weights were significantly lower for 5000 and 50,000 ppm males. However, since there were no histopathological lesions in these organs which could be related to the difference in weights, the lower mean absolute and relative weights were considered to be related to the lower body weight. Females exposed to 15,000 ppm had significantly lower mean relative kidney weights. However, since there were no differences at the higher exposure concentration, this observation was considered to be spurious. There were no compound-related gross or microscopic morphological changes observed at any exposure concentration in either males or females at the 90-day or 1 -month sacrifices.
At the 90-day sacrifice, hepatic beta-oxidation activity was twofold higher in male mice at all exposure concentrations than in control values (Table 4 ). The increased betaoxidation activity may be associated with decreased triglyceride concentration and the decreased body weights. However, the relative increase in beta-oxidation activity was small compared to classical inducers (clofibrate, tibricacid, Wy-14,643) of beta-oxidation activity (Lazarow, 1977) . Furthermore, there were no differences in liver weight or morphology and the data did not exhibit a dose-response relationship. Therefore, the increased beta-oxidation activity was not considered to result in biologically adverse effects in the mice. At the end of the recovery period, there were no compound-related effects for any exposure concentration. In females, hepatic beta-oxidation activity was similar to control values for all exposure concentrations at both the 90-day sacrifice and the 1-month recovery period.
Rat Developmental Study
Maternal body weight gain of rats exposed to 50,000 ppm was lower during the first several days of exposure (GD 7-9); however, there were no significant differences in body weight prior to exposure or in the postexposure period (Table  5 ). The lower body weight correlates with lower food consumption during GD 7-13 (statistically significant only for GD 9-11). However, during the postexposure period, food consumption was increased for 15,000 and 50,000 ppm females. Rats that could be observed during exposure were less responsive to auditory stimuli at 50,000 ppm than those at lower concentrations. During nonexposure periods, however, there were no compound-related effects on the incidence of clinical signs of toxicity during gestation, and no unscheduled deaths occurred during gestation.
There were no compound-related effects at any exposure concentration on the number of corpora lutea, implantation sites, preimplantation losses, resorptions, pregnancies, and live fetuses per litter (Table 6 ). In addition, there were no compound-related effects on fetal weight or the incidence of stunted fetuses.
There were no significant trends or differences in incidence of litters or fetuses per litter with external, visceral, head, or skeletal malformations or variations compared to control at any exposure concentration (Table 7) . The control, low, intermediate, and high concentration groups had a total of zero, two, three, and four affected litters, respectively, with one affected fetus in each litter. At the 50,000 ppm concentration, the most severely affected fetus had axial skeletal malformations (exencephaly, spina bifida, and filamentous tail) and anasarca; the other three affected fetuses in that group had a ringed aorta, anasarca, and a fused rib, respectively. At the 15,000 ppm concentration, single instances of hemivertebrae with fused ribs, hydrocephaly, and imperforate anus with filamentous tail were detected. One fetus with gastroschisis and one with fused ribs were noted in the 5000 ppm group. Although there appears to be a doserelated trend with respect to the incidence of affected litters, there are no trends evident with regard to the type of malformations/variations observed. Each affected fetus had a different type or array of malformation(s)/variation(s), and therefore they were not considered to be compound related.
Rabbit Developmental Study
There were no compound-related effects on maternal body weight or body weight gain during gestation (Table 8) . During the preexposure period (GD 0-6), body weight gain was similar between all treatment groups and the animals were gaining weight as expected. However, at the beginning of the exposure period, a mean weight loss was observed in all groups, including control. For the remainder of the exposure period (GD 9-19), comparable mean body weight gains were observed in all groups. During the postexposure period (20) 261 (17) 286 (20) 128 (18) 160 (20) 136 (17) 147 (20) 245 (18) 306 (20) 261 (17) 286 (20) 127 (18) 158 (20) 135 (17) 147 (20) No. affected (GD 19-30), maternal body weight gain was higher for 5000, 15,000, and 50,000 ppm dams (Table 8) . Although this effect appears to be compound related, it was not considered to be adverse since there were no corresponding adverse effects in other associated parameters. Maternal food consumption was similar to control during the preexposure phase. Food consumption values for 50,000 ppm females were lower during the GD 7-13 interval, however, and ranged up to 16% lower than control values on GD 12-13. During the postexposure gestation period, food consumption of 50,000 ppm females was slightly higher than control values, which was suggestive of compensatory feeding. Rabbits that could be observed during exposure were less active at 50,000 ppm than those at lower concentrations. During nonexposure periods, however, there were no compoundrelated effects on the incidence of clinical signs of toxicity during gestation, and compound-related mortality did not occur during gestation. There were no compound-related effects at any exposure concentration on the number of corpora lutea, implantation sites, preimplantation losses, resorptions, pregnancies, and live fetuses per litter (Table 6 ). In addition, there were no compound-related effects on fetal weight or the incidence of stunted fetuses. There were no significant trends or differences in incidence of litters or fetuses per litter with external, visceral, or skeletal malformations or variations compared to control at any exposure concentration (Table 7) . The number of affected litters with respect to external malformations was 1, 1,0, and 0 for 0, 5000, 15,000, and 50,000 ppm groups, respectively. The number of affected litters for visceral malformations was 0, 2, 1, and 3 for 0, 5000, 15,000, and 50,000 ppm, respectively. The 50,000 ppm group had a higher incidence relative to control which represented three affected fetuses from three different litters. Two of the three affected fetuses had similar heart and aortic arch malformations (1.3%), with one of the fetuses having additional findings consisting of excessive fluid in the abdominal and thoracic cavities, diaphragmatic hernia, abnormal course of the right subclavian artery, and a cyst-like structure on the liver. Although two of the three affected fetuses had similar cardiac and aortic malformations and the percentage incidence for this malformation in 50,000 ppm rabbits was higher relative to the control, the percentage incidence was within the range of historical controls for the laboratory. Therefore, these cardiac/aortic malformations were not considered to be compound related. The third affected fetus had an absent spleen, which was considered to be unrelated to the compound exposure since it was an isolated instance. The number of affected litters with skeletal malformations were 4, 10, 5, and 8 for 0, 5000, 15,000, and 50,000 ppm groups, respectively. The most frequent malformation observed was the angulated arch of the hyoid and occurred with similar 64 (8) 61 (11) 58 (10) 53 (13) 56 (7) 53 (8) 54 (7) 58 (10) 28 (15) 61 (9) 59 (9) 55 (7) 54 (6) 52 (7) 51 (9) 44 (12) 52 (14) 25 (13) 50,000 (
148 (101 frequency among all groups (2.0, 4.3, 1.7, and 3.1% for 0, 5000, 15,000, and 50,000 ppm groups, respectively). The incidences of other skeletal malformations were 0.7, 3.4, 2.4, and 3.9% for 0, 5000, 15,000, and 50,000 ppm groups, respectively. There were no dose-related trends in the types of skeletal malformations and all malformations occurred with a frequency that was similar to the historical control range for the laboratory. Therefore, a compound-related effect on skeletal malformations was not observed.
DISCUSSION
Previous studies with hydrohalocarbons have been conducted predominately with rats. These present studies therefore allow an opportunity to compare the results obtained with the rat to those seen with a second species, the mouse. Also, as these studies are part of a series of studies conducted with pentahaloethanes, the effect of increasing the substitution of fluorine for chlorine on the resultant toxicity can be compared. The three compounds compared in this series of studies are l,l-dichloro-2,2,2-trifluoroethane (HCFC-123), l-chloro-l,2,2,2-tetrafluoroethane (HCFC-124), and pentafiuoroethane (HFC-125).
Male and female rats and mice exposed by inhalation to HCFC-124 for 6 hr per day, 5 days per week, for approximately 13 weeks had minimal but similar compound-related effects. Minimally decreased serum triglycerides were observed in both 15,000 and 50,000 ppm male rats and male mice; however, the magnitude of the effect in mice appeared to be greater than the effect in rats, and was consistent with the slightly lower body weight and slightly higher hepatic beta-oxidation activity in the mouse.
During the daily exposure period, rats (including rats utilized for the developmental study) and mice exposed to 50,000 ppm were less responsive to auditory stimuli than controls, as demonstrated by a decreased reaction to a knock on the exposure chamber wall. Rabbits in the developmental study were also less active during the exposure to 50,000 ppm HCFC-124. Similarly, in a previous 2-week study (Trochimowicz et ai, 1977) , rats exposed to 100,000 ppm exhibited poor coordination, lethargy, anesthesia, irregular respiration, and sporadic tremors. However, approximately 15 min after exposure, no compound-related clinical observations were detected. Although the animals appeared to recover quickly from these sedative types of effects, such that they appeared to be normal in their home cages, decreased arousal was observed in 15,000 and 50,000 ppm male rats during the evaluation of functional observational battery parameters conducted after 13 weeks of exposure. The decreased arousal observed in an open field environment may be related to the sedative type of effects observed during exposure. It should be noted that the decreased arousal was not evident until after the animals had been exposed for 13 weeks, and the arousal of 50,000 ppm rats was similar to that seen in controls after a 1-month recovery period, indicating that it is a transient effect.
For rats, increases in plasma and urinary fluoride concentrations at all exposure levels were an expected physiological consequence of exposure to the fluorinated compound due to metabolism of the compound (Olson et ai, 1991) . The continued excretion of fluoride ion in the urine at the end of the 1 -month recovery period may be a reflection of gradual release of stored fluoride which may have accumulated over the course of the study into a depot such as bone. However, there did not appear to be any adverse effects associated with the prolonged excretion of fluoride ion after a 1-month recovery period, and therefore, this was not considered to be an adverse effect.
HCFC-124 was not a developmental toxin in either rats or rabbits at concentrations up to 50,000 ppm. There was some evidence of maternal toxicity at 50,000 ppm in both rats and rabbits since rats and rabbits had lower food consumption, and rats also had lower body weight gains during the exposure phase of the study. However, dams of both species appeared to recover during the postexposure phase, and no compound-related effects were detected on any fetal parameters.
